Aculys

Acquired

Aculys Pharma, Inc.

Tokyo, Japan · Founded 2021 · $114.0M raised

Headquarters
Tokyo
Founded
2021
Business Model
B2B
Website
aculys.com
Total Funding
$114.0M
Last Round
$30.0M Series CMar 2025
Rounds
3
Acquisition Date
Oct 2025

About

Aculys Pharma is a clinical-stage biopharmaceutical company headquartered in Tokyo that works to eliminate Japan's 'drug lag' and 'drug loss' by licensing and commercializing innovative neurology treatments already approved abroad. Its pipeline includes pitolisant (licensed from France's Bioprojet) for narcolepsy and obstructive sleep apnea, and a diazepam nasal spray (Spydia) for epileptic seizures licensed from US-based Neurelis. The company was acquired by Viatris in October 2025.

Summary

Aculys is a Biotech company based in Tokyo, Japan, founded in 2021. It has raised $114.0M in total across 3 rounds, most recently a $30.0M Series C round in Mar 2025. Investors include SoftBank, Catalys Pacific and HBM Healthcare Investments.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionAcquisition by ViatrisOct 2025

Sign up to see all 4 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aculys on Indexed.vc
<a href="https://indexed.vc/companies/aculys"><img src="https://indexed.vc/api/badge/company/aculys" alt="Aculys on Indexed.vc" width="260" height="76" /></a>